WP 631 and Epo B synergize in SKOV-3 human ovarian cancer cells
Author:
Publisher
Elsevier BV
Subject
Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,General Medicine
Reference38 articles.
1. Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues;Ashikawa;Biochem. Pharmacol.,2004
2. Phase I–II study of pegylated liposomal doxorubicin combined with weekly paclitaxel as first-line treatment in patients with metastatic breast cancer;Bourgeois;Am. J. Clin. Oncol.,2006
3. The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells;Brooks;Invest. New Drugs,2007
4. New emerging drugs targeting the genomic integrity and replication machinery in ovarian cancer;Brüning;Arch. Gynecol. Obstet.,2011
5. Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors;Campos;Gynecol. Oncol.,2003
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New chalcone-tethered 1,3,5-triazines potentiate the anticancer effect of cisplatin against human lung adenocarcinoma A549 cells by enhancing DNA damage and cell apoptosis;Bioorganic Chemistry;2020-12
2. Therapeutic potential of patupilone in epithelial ovarian cancer and future directions;Life Sciences;2018-07
3. Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells;Toxicology in Vitro;2018-03
4. New potential chemotherapy for ovarian cancer — Combined therapy with WP 631 and epothilone B;Life Sciences;2016-04
5. High Potency of a Novel Resveratrol Derivative, 3,3′,4,4′-Tetrahydroxy-trans-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and Repair;Oxidative Medicine and Cellular Longevity;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3